HAEM4:Acute Myeloid Leukemia (AML) with Mutated RUNX1: Difference between revisions
Bailey.Glen (talk | contribs) Created page with "==Primary Author(s)*== Iris Martin, M.D. Daynna J. Wolff, Ph.D. __TOC__ ==Cancer Category/Type== Acute Myeloid Leukemia ==Cancer Sub-Classification / Subtype== Acute My..." |
Bailey.Glen (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Acute Myeloid Leukemia (AML) with Mutated RUNX1}} | |||
<blockquote class='blockedit'>{{Box-round|title=PREVIOUS EDITION|This page from the 4th edition of Haematolymphoid Tumours is being updated. See 5th edition [[HAEM5:Table_of_Contents|Table of Contents]]. | |||
}}</blockquote> | |||
==Primary Author(s)*== | ==Primary Author(s)*== | ||
| Line 60: | Line 65: | ||
==Chromosomal Rearrangements (Gene Fusions)== | ==Chromosomal Rearrangements (Gene Fusions)== | ||
The ''RUNX1'' gene is involved in the 8;21 translocation (see [http://www.ccga.io/index.php/ | The ''RUNX1'' gene is involved in the 8;21 translocation (see [http://www.ccga.io/index.php/HAEM5:Acute_myeloid_leukaemia_with_RUNX1::RUNX1T1_fusion Acute Myeloid Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1] page), but the AML with mutated ''RUNX1'' subcategory is specific for those cases with a somatic, acquired mutation in the ''RUNX1'' gene. | ||
==Characteristic Chromosomal Aberrations / Patterns== | ==Characteristic Chromosomal Aberrations / Patterns== | ||
| Line 130: | Line 135: | ||
==Notes== | ==Notes== | ||
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome. | <nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome. | ||
[[Category:HAEM4]] [[Category:DISEASE]] | |||
[[Category: | |||
[[Category: | |||